Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
MEDGm vs SkinnyRx
MEDGm and SkinnyRx both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
MEDGm
Ranked #68 for women · Grade C
Luna Fit
Best for: Women who want to know which pharmacies fill the prescription before they start, and who will turn down the twelve-month plan once they read what renewing it costs.
Visit MEDGmSkinnyRx
Higher scoreRanked #54 for women · Grade C
Luna Fit
Best for: Readers treating insulin resistance who want the dual GIP/GLP-1 molecule without a weekly injection, and who will open the plan selector and read the month-to-month rate rather than the advertised one.
FDA warning letterFebruary 2026Read it ↗Visit SkinnyRxThe verdict for women
SkinnyRx edges out MEDGm on the Luna Fit Score, 71 to 68 (C vs C). Readers treating insulin resistance who want the dual GIP/GLP-1 molecule without a weekly injection, and who will open the plan selector and read the month-to-month rate rather than the advertised one. The reasoning behind that number is in the SkinnyRx scorecard.
MEDGm is still a genuine option — names all four dispensing pharmacies with addresses and phone numbers, then hides the price behind a sixteen-screen intake. A $179 first month renews at $299, on a page whose own FAQ promises the price never increases. Weigh the six women's-health factors below against your own priorities; the MEDGm scorecard goes through each of them, and if neither of these two is the one, the alternatives to MEDGm we rank for women widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | MEDGm | SkinnyRx |
|---|---|---|
| Luna Fit Score | 68/100 · C | 71/100 · C |
| Overall rank | #68 | #54 |
| Semaglutide | $299/mo month-to-month injection ($179 the first month only, on a coupon applied automatically); prepay $249, $219 or $169 a month on three, six or twelve months billed upfront | $349/mo month-to-month (from $199/mo on a 12-month plan) — the site displays only the 12-month rate |
| Tirzepatide | $399/mo month-to-month injection ($279 first month only); prepay $349, $319 or $269 a month on three, six or twelve months billed upfront | $399/mo month-to-month, injectable or dissolving tablet (from $299/mo on a 12-month plan) — the site displays only the 12-month rate |
| Coverage | All 50 states and DC, matching its own intake selector | No state list published; the offer terms report no state restrictions |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
MEDGm
Ranked #68 · Grade C
What we like
- Names all four dispensing pharmacies with street addresses and phone numbers — RedRock, Health Warehouse, Precision Medicine and Triad Rx
- States the 503A and 503B classes and names the prescribing entities: seven OpenLoop professional corporations and Reliant MD
- Coverage is fifty states and DC in the terms and in the intake selector, with no contradiction between the two
The caveats
- No price appears until a sixteen-screen intake ending in name, email and phone number is finished
- The advertised $179 is a first-month coupon rate; the standing figure is $299, and removing the coupon rewrites the panel on the spot
- The treatments FAQ promises the price never increases, on the same page where a month-to-month plan rises from $179 to $299 at the first renewal
Luna Fit
SkinnyRx
Ranked #54 · Grade C
What we like
- A compounded tirzepatide TABLET — a dissolving sublingual route for the dual GIP/GLP-1 molecule, priced identically to the injection at every rung, which is close to unique in this ranking
- Both molecules across three routes — injection, sublingual and daily tablet — so needle aversion never means changing provider or dropping back to the single-pathway drug
- Lower-dose "microdose" lines for both molecules are sold as their own products with their own published ladders, rather than being quoted at the full-dose price
The caveats
- Carries an active FDA warning letter issued in February 2026 (see the notice on this page for FDA's own record)
- Every price the site advertises is the TWELVE-MONTH rung: its own headline reads "Starting at $299/mo" while the month-to-month tirzepatide rate is $399 and the renewal price in its code is literally 399 — semaglutide is the same shape at $199 advertised against $349 month-to-month
- The commitment is not named beside the number anywhere in the marketing copy, and the prepay rung is also what its schema.org product markup publishes as the price — so search engines and AI assistants are given the twelve-month rate as though it were the monthly one
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither MEDGm nor SkinnyRx is only worth comparing with the other. MEDGm is also written up against CoreAge Rx, 25 points apart on the Luna Fit Score — see MEDGm against CoreAge Rx, factor by factor. SkinnyRx is also written up against CoreAge Rx, 22 points apart — see the SkinnyRx–CoreAge Rx head-to-head.
- MEDGm vs CoreAge Rx
- MEDGm vs Enhance MD
- MEDGm vs Eden
- SkinnyRx vs yourEra
- SkinnyRx vs Sesame Care
- SkinnyRx vs HealthRX
Or browse the full comparison hub.